These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37328360)

  • 1. Anosmia during acute COVID-19 and psychiatric outcomes 4 months later: Results from the prospective COMEBAC cohort.
    Faulet T; Gasnier M; Lecoq AL; Morin L; Choucha W; Montani D; Monnet X; Becquemont L; Corruble E; Colle R;
    Gen Hosp Psychiatry; 2023; 84():260-261. PubMed ID: 37328360
    [No Abstract]   [Full Text] [Related]  

  • 2. Olfactory disorder in patients infected with SARS-CoV-2.
    Yen YF; Lai HH; Chan SY; Su VY; Chiu TF; Huang CY; Hung CC; Kuo TL; Lee YL; Chu D
    J Microbiol Immunol Infect; 2021 Oct; 54(5):992-996. PubMed ID: 32859529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 patient with recurrent anosmia and its impact on management.
    Rizki NA; Lukito PP; Helsa K; Rustandi D
    Eur Ann Otorhinolaryngol Head Neck Dis; 2022 Mar; 139(2):115-116. PubMed ID: 34481758
    [No Abstract]   [Full Text] [Related]  

  • 4. [Loss of smell, a preliminary indicator of COVID-19].
    Waizel-Haiat S; Waizel-Bucay J
    Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-related anosmia.
    Kanaganayagam E; Lloyd G; Travers L; Morris J; Chang A
    Aust J Gen Pract; 2022 Apr; 51():. PubMed ID: 35393605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological relationship between COVID-19 and olfactory dysfunction: A systematic review.
    Las Casas Lima MH; Cavalcante ALB; Leão SC
    Braz J Otorhinolaryngol; 2022; 88(5):794-802. PubMed ID: 33965353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
    Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiological mechanisms and management of patients with long-time anosmia related to COVID-19.
    Lechien JR; Chiesa-Estomba CM; Hans S; Saussez S
    J Intern Med; 2021 Aug; 290(2):464-465. PubMed ID: 33527593
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.
    Rethinavel HS; Ravichandran S; Radhakrishnan RK; Kandasamy M
    J Chem Neuroanat; 2021 Sep; 115():101965. PubMed ID: 33989761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beware of traumatic anosmia in COVID-19 pandemic.
    Nagamine T
    CJEM; 2021 Jul; 23(4):567-568. PubMed ID: 33881763
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring of cases of anosmia and COVID-19.
    Sookaromdee P; Wiwanitkit V
    Braz J Otorhinolaryngol; 2021; 87(5):638. PubMed ID: 33992555
    [No Abstract]   [Full Text] [Related]  

  • 12. [COVID-19-associated anosmia].
    Meller AE; Fokeev VA; Shakhova MA; Shakhov AV
    Vestn Otorinolaringol; 2023; 88(3):63-68. PubMed ID: 37450393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Response to Anosmia and Ageusia: Common Findings in COVID-19 Patients.
    Vaira LA; Salzano G; Deiana G; De Riu G
    Laryngoscope; 2020 Nov; 130(11):E695. PubMed ID: 32673407
    [No Abstract]   [Full Text] [Related]  

  • 14. In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients.
    Chang YP; Yang CJ; Chen YH
    Laryngoscope; 2020 Nov; 130(11):E694. PubMed ID: 32673402
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients.
    Vaira LA; Lechien JR; Salzano G; Maglitto F; Saussez S; De Riu G
    Am J Otolaryngol; 2022; 43(3):103301. PubMed ID: 34895763
    [No Abstract]   [Full Text] [Related]  

  • 16. Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.
    Hannum ME; Ramirez VA; Lipson SJ; Herriman RD; Toskala AK; Lin C; Joseph PV; Reed DR
    Chem Senses; 2020 Dec; 45(9):865-874. PubMed ID: 33245136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Evaluation of a Potential Non-Invasive Neurostimulation Strategy for Treating Persistent Anosmia in Post-COVID-19 Patients.
    Gracia DI; Ortiz M; Candela T; Iáñez E; Sánchez RM; Díaz C; Azorín JM
    Sensors (Basel); 2023 Jun; 23(13):. PubMed ID: 37447728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New study on prevalence of anosmia in COVID-19 implicates the D614G virus mutation as a major contributing factor to chemosensory dysfunction.
    von Bartheld CS; Mathew D; Butowt R
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3593-3594. PubMed ID: 33788036
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemosensory loss in COVID-19.
    Xu W; Sunavala-Dossabhoy G; Spielman AI
    Oral Dis; 2022 Nov; 28 Suppl 2():2337-2346. PubMed ID: 35790059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19.
    Moraschini V; Reis D; Sacco R; Calasans-Maia MD
    Oral Dis; 2022 Nov; 28 Suppl 2():2533-2537. PubMed ID: 34002923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.